Results 271 to 280 of about 188,791 (289)

Treatment of childhood autoimmune haemolytic anaemia with rituximab

Lancet, The, 2001
Pierre Quartier
exaly  

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Lancet, The, 2017
Pascal Joly, Maud Maho-Vaillant, Catherine Prost-Squarcioni   +2 more
exaly  

Rituximab

Reactions Weekly, 2014
openaire   +2 more sources

Rituximab for idiopathic membranous nephropathy

Lancet, The, 2002
Giuseppe Remuzzi
exaly  

Rituximab

Reactions Weekly, 2009
openaire   +1 more source

Rituximab

Reactions Weekly, 2020
openaire   +1 more source

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation

Lancet, The, 1999
Randy D Gascoyne, Joseph M Connors
exaly  

Rituximab

Reactions Weekly, 2018
  +4 more sources

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Lancet, The, 2019
Mathias Witzens-Harig, Harald Holte, Lorenz Thurner   +2 more
exaly  

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2019
Tait D Shanafelt, Neil E Kay, Susan M O'brien   +2 more
exaly